Oregon Public Employees Retirement Fund grew its holdings in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 8.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,556 shares of the medical instruments supplier’s stock after purchasing an additional 511 shares during the period. Oregon Public Employees Retirement Fund’s holdings in ICU Medical were worth $1,505,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also bought and sold shares of the company. We Are One Seven LLC bought a new position in shares of ICU Medical during the 4th quarter valued at about $32,000. Financial Gravity Companies Inc. bought a new position in shares of ICU Medical during the 4th quarter valued at about $45,000. Bogart Wealth LLC bought a new position in shares of ICU Medical during the 4th quarter valued at about $51,000. Huntington National Bank boosted its position in shares of ICU Medical by 26.6% during the 4th quarter. Huntington National Bank now owns 443 shares of the medical instruments supplier’s stock valued at $102,000 after purchasing an additional 93 shares in the last quarter. Finally, MML Investors Services LLC bought a new position in shares of ICU Medical during the 3rd quarter valued at about $217,000. Institutional investors own 83.54% of the company’s stock.
Shares of ICUI traded up $0.75 during midday trading on Monday, hitting $247.46. The stock had a trading volume of 4,678 shares, compared to its average volume of 134,666. ICU Medical, Incorporated has a fifty-two week low of $210.94 and a fifty-two week high of $321.70. The stock has a market cap of $5.05 billion, a price-to-earnings ratio of 44.83 and a beta of 0.68.
Several research analysts have commented on the stock. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “strong-buy” rating and set a $297.00 target price for the company in a report on Thursday, November 1st. ValuEngine cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, November 6th. Finally, BidaskClub cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 8th.
In other news, Director Pfizer Inc sold 2,500,000 shares of the stock in a transaction that occurred on Thursday, November 15th. The shares were sold at an average price of $209.25, for a total value of $523,125,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert S. Swinney sold 1,500 shares of the stock in a transaction that occurred on Monday, January 28th. The stock was sold at an average price of $242.19, for a total transaction of $363,285.00. Following the completion of the sale, the director now directly owns 19,540 shares of the company’s stock, valued at $4,732,392.60. The disclosure for this sale can be found here. Company insiders own 12.50% of the company’s stock.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: Return on Equity (ROE)
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.